MR Spectroscopy in Radiation Injury

References

1. ↵
   1. Walker MD,
   2. Strike TA,
   3. Sheline GE

   . An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979; 5: 1725– 31

   CrossRefPubMedWeb of Science
2. ↵
   1. Johannesen TB,
   2. Lien HH,
   3. Hole KH,
   4. et al

   . Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy. Radiother Oncol 2003; 69: 169– 76

   CrossRefPubMed
3. ↵
   1. Bonavita S,
   2. Di Salle F,
   3. Tedeschi G

   . Proton MRS in neurological disorders. Eur J Radiol 1999; 30: 125– 31

   CrossRefPubMedWeb of Science
4. ↵
   1. Langleben DD,
   2. Segall GM

   . PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 2000; 41: 1861– 67

   Abstract/FREE Full Text
5. ↵
   1. Terakawa Y,
   2. Tsuyuguchi N,
   3. Iwai Y,
   4. et al

   . Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 2008; 49: 694– 99

   Abstract/FREE Full Text
6. ↵
   1. Hein PA,
   2. Eskey CJ,
   3. Dunn JF,
   4. et al

   . Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 2004; 25: 201– 09

   Abstract/FREE Full Text
7. ↵
   1. Sundgren PC,
   2. Fan X,
   3. Weybright P,
   4. et al

   . Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast enhancing lesions. Magn Reson Imaging 2006; 24: 1131– 42. Epub 2006 Sep 18

   CrossRefPubMedWeb of Science
8. ↵
   1. Sugahara T,
   2. Korogi Y,
   3. Tomiguchi S,
   4. et al

   . Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000; 21: 901– 09

   Abstract/FREE Full Text
9. ↵
   1. Jain R,
   2. Scarpace L,
   3. Ellika S,
   4. et al

   . First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors from radiation effects and radiation necrosis. Neurosurgery 2007; 61: 778– 86

   PubMedWeb of Science
10. ↵
    1. Di Chiro G,
    2. Oldfield E,
    3. Wright DC

    . Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol 1988; 150: 189– 97

    CrossRefPubMedWeb of Science
11. ↵
    1. Thompson TP,
    2. Lunsford LD,
    3. Kondziolka D

    . Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy. Stereotact Funct Neurosurg 1999; 73: 9– 14

    CrossRefPubMed
12. ↵
    1. Carvalho PA,
    2. Schwartz RB,
    3. Alexander E,
    4. et al

    . Detection of recurrent gliomas with qualitative thallium-201/technetium 99m HMPAO single-photon emission computerized tomography. J Neurosurg 1992; 77: 565– 70

    PubMed
13. ↵
    1. Schwartz RB,
    2. Carvalho PA,
    3. Alexander E,
    4. et al

    . Radiation necrosis vs high-grade recurrent glioma: differentiation by using dualisotope SPECT with 201Tl and 99mTc-HMPAO. AJNR Am J Neuroradiol 1991; 12: 1187– 92

    Abstract/FREE Full Text
14. ↵
    1. Schwartz RB,
    2. Holman BL,
    3. Polak JF,
    4. et al

    . Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg 1998; 89: 60– 68

    PubMedWeb of Science
15. ↵
    1. Matheja P,
    2. Rickert C,
    3. Weckesser M,
    4. et al

    . Scintigraphic pitfall: delayed radionecrosis—case illustration. J Neurosurg 2000; 92: 732

    CrossRefPubMed
16. ↵
    1. Barajas RF,
    2. Chang JS,
    3. Sneed PK,
    4. et al

    . Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2009; 30: 367– 72. Epub 2008 Nov 20

    Abstract/FREE Full Text
17. ↵
    1. Kumar AJ,
    2. Leeds NE,
    3. Fuller GN,
    4. et al

    . Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000; 217: 377– 84

    CrossRefPubMedWeb of Science
18. ↵
    1. Marks JE,
    2. Baglan RJ,
    3. Prassad SC,
    4. et al

    . Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 1981; 7: 243– 52

    CrossRefPubMedWeb of Science
19. ↵
    1. Belka C,
    2. Budach W,
    3. Kortmann RD,
    4. et al

    . Radiation-induced CNS toxicity: molecular and cellular mechanisms. Br J Cancer 2001; 85: 1233– 9

    CrossRefPubMedWeb of Science
20. ↵
    1. Swaya MD

    1. Sawaya R

    . The fibrinolytic enzymes in the biology of brain tumors. In: Swaya MD. Fibrinolysis and the Central Nervous System. Philadelphia: Hanley and Belfus; 1990: 106– 26
21. ↵
    1. Castel JC,
    2. Caille JM

    . Imaging of irradiated brain tumors: value of magnetic resonance imaging. J Neuroradiol 1989; 16: 81– 132

    PubMed
22. ↵
    1. Gutin PH,
    2. Leibel SA,
    3. Sheline GE

    1. Burger PC,
    2. Boyko OB

    . The pathology of central nervous system radiation injury. In: Gutin PH, Leibel SA, Sheline GE. Radiation Injury to the Nervous System. New York: Raven; 1991: 191– 208
23. ↵
    1. Khong PL,
    2. Leung LH,
    3. Fung AS,
    4. et al

    . White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J Clin Oncol 2006; 24: 884– 90

    Abstract/FREE Full Text
24. ↵
    1. Moretti R,
    2. Torre P,
    3. Antonello RM,
    4. et al

    . Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia. J Neurol Sci 2005; 229–230: 195– 200. Epub 2004 Dec 19
25. ↵
    1. Cole PD,
    2. Kamen BA

    . Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia. Ment Retard Dev Disabil Res Rev 2006; 12: 174– 83

    CrossRefPubMed
26. ↵
    1. Herman MA,
    2. Tremont-Lukats I,
    3. Meyers CA,
    4. et al

    . Neurocognitive and functional assessment of patients with brain metastases: a pilot study. Am J Clin Oncol 2003; 26: 273– 79

    CrossRefPubMed
27. ↵
    1. Constine LS,
    2. Konski A,
    3. Ekholm S,
    4. et al

    . Adverse effects of brain irradiation correlated with MR and CT imaging. Int J Radiat Oncol Biol Phys 1988; 15: 319– 30

    CrossRefPubMedWeb of Science
28. ↵
    1. Packer RJ,
    2. Zimmerman RA,
    3. Bilaniuk LT

    . Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage. Cancer 1986; 58: 635– 40

    CrossRefPubMed
29. ↵
    1. Price RE,
    2. Langford LA,
    3. Jackson EF,
    4. et al

    . Radiation-induced morphologic changes in the rhesus monkey (Macaca mulatta) brain. J Med Primatol 2001; 30: 81– 87

    CrossRefPubMed
30. ↵
    1. Benczik J,
    2. Tenhunen M,
    3. Snellman M,
    4. et al

    . Late radiation effects in the dog brain: correlation of MRI and histological changes. Radiother Oncol 2002; 63: 107– 20

    CrossRefPubMed
31. ↵
    1. Chiang CS,
    2. McBride WH,
    3. Withers HR

    . Myelin-associated changes in mouse brain following irradiation. Radiother Oncol 1993; 27: 229– 36

    CrossRefPubMed
32. ↵
    1. Burger PC,
    2. Mahley MS Jr.,
    3. Dudka L,
    4. et al

    . The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer 1979; 44: 1256– 72

    CrossRefPubMedWeb of Science
33. ↵
    1. Armstrong CL,
    2. Gyato K,
    3. Awadalla AW,
    4. et al

    . A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy. Neuropsychol Rev 2004; 14: 65– 86

    CrossRefPubMedWeb of Science
34. ↵
    1. Mikhael MA

    . Radiation necrosis of the brain: correlation between patterns on CT and dose of radiation. J Comput Assist Tomogr 1979; 3: 241– 49

    PubMedWeb of Science
35. ↵
    1. Nagesh V,
    2. Tsien CI,
    3. Chenevert TL,
    4. et al

    . Radiation-induced changes in normal-appearing white matter in patients with cerebral tumors: a diffusion tensor imaging study. Int J Radiat Oncol Biol Phys 2008; 70: 1002– 10

    PubMed
36. ↵
    1. Sundgren PC,
    2. Nagesh V,
    3. Elias A,
    4. et al

    . Metabolic alterations: a biomarker for radiation-induced injury of normal brain—a spectroscopy study. J Magn Reson Imaging 2009; 29: 291– 97

    CrossRefPubMed
37. ↵
    1. Lee MC,
    2. Pirzkall A,
    3. McKnight TR,
    4. et al

    . 1H-MRS of radiation effects in normal-appearing white matter: dose-dependence and impact on automated spectral classification. J Magn Reson Imaging 2004; 19: 379– 88

    CrossRefPubMedWeb of Science
38. ↵
    1. Tofilon PJ,
    2. Fike JR

    . The radioresponse of the central nervous system: a dynamic process. Radiat Res 2000; 153: 357– 70

    CrossRefPubMedWeb of Science
39. ↵
    1. Bates TE,
    2. Strangeward M,
    3. Keelan J,
    4. et al

    . Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 1992; 7: 1397– 400
40. ↵
    1. de Stefano N,
    2. Matthews PM,
    3. Arnold DL

    . Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995; 34: 721– 27

    CrossRefPubMedWeb of Science
41. ↵
    1. Estève F,
    2. Rubin C,
    3. Grand S,
    4. et al

    . Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Int J Radiat Oncol Biol Phys 1998; 40: 279– 86

    CrossRefPubMedWeb of Science
42. ↵
    1. Chan YL,
    2. Roebuck DJ,
    3. Yuen MP,
    4. et al

    . Long-term cerebral metabolite changes on proton magnetic resonance spectroscopy in patients cured of acute lymphoblastic leukemia with previous intrathecal methotrexate and cranial irradiation prophylaxis. Int J Radiat Oncol Biol Phys 2001; 50: 759– 63

    CrossRefPubMedWeb of Science
43. ↵
    1. Isobe T,
    2. Matsumura A,
    3. Anno I,
    4. et al

    . Changes in 1H-MRS in glioma patients before and after irradiation: the significance of quantitative analysis of choline-containing compounds [in Japanese]. No Shinkei Geka 2003; 31: 167– 72

    PubMed
44. ↵
    1. Walecki J,
    2. Sokól M,
    3. Pieniazek P,
    4. et al

    . Role of short TE 1H-MR spectroscopy in monitoring of post-operation irradiated patients. Eur J Radiol 1999; 30: 154– 61

    CrossRefPubMed
45. ↵
    1. Kitahara S,
    2. Nakasu S,
    3. Murata K,
    4. et al

    . Evaluation of treatment-induced cerebral white matter injury by using diffusion-tensor MR imaging: initial experience. AJNR Am J Neuroradiol. 2005; 26: 2200– 06

    Abstract/FREE Full Text
46. ↵
    1. Sundgren PC,
    2. Rogers L,
    3. Tsien CT,
    4. et al

    . Correlation of Magnetic Resonance Imaging Morphologic Abnormalities, Magnetic Resonance Spectroscopy and Radiation Treatment Dose-Volumes in Histological Proven Cerebral Radiation Necrosis. Proceedings of the European Society of Neuroradiology, Krakow, Poland, September 18–21, 2008
47. ↵
    1. Chong VF,
    2. Rumpel H,
    3. Fan YF,
    4. et al

    . Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings. Eur Radiol 2001; 11: 317– 24

    CrossRefPubMed
48. ↵
    1. Chong VF,
    2. Rumpel H,
    3. Aw YS,
    4. et al

    . Temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma: 1H MR spectroscopic findings. Int J Radiat Oncol Biol Phys 1999; 45: 699– 705

    CrossRefPubMed
49. ↵
    1. Schlemmer JP,
    2. Bachert P,
    3. Henze M,
    4. et al

    . Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology 2002; 44: 216– 22

    CrossRefPubMedWeb of Science
50. ↵
    1. Schlemmer HP,
    2. Bachert P,
    3. Herfarth K,
    4. et al

    . Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 2001; 22: 1316– 24

    Abstract/FREE Full Text
51. ↵
    1. Castillo M,
    2. Kwock L,
    3. Mukherji SK

    . Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996; 17: 1– 15

    PubMedWeb of Science
52. ↵
    1. Yeung DK,
    2. Chan Y,
    3. Leung S,
    4. et al

    . Detection of an intense resonance at 2.4 ppm in 1H MR spectra of patients with severe late-delayed, radiation-induced brain injuries. Magn Reson Med 2001; 45: 994– 1000

    CrossRefPubMed
53. ↵
    1. Rock JP,
    2. Scarpace L,
    3. Hearshen D,
    4. et al

    . Associations among magnetic resonance spectroscopy, apparent diffusion coefficients and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 2004: 54; 1111– 19

    PubMedWeb of Science
54. ↵
    1. Weybright P,
    2. Sundgren PC,
    3. Maly P,
    4. et al

    . Differentiation between brain tumour recurrence and radiation injury using MR spectroscopy. AJR Am J Roentgenol 2005; 185: 1471– 76

    CrossRefPubMedWeb of Science
55. ↵
    1. Rock JP,
    2. Hearshen D,
    3. Scarpace L,
    4. et al

    . Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 2002; 51: 912– 19

    CrossRefPubMedWeb of Science
56. ↵
    1. Zeng QS,
    2. Li CF,
    3. Zhang K,
    4. et al

    . Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol 2007; 84: 63– 69

    CrossRefPubMed
57. ↵
    1. Kimura T,
    2. Sako K,
    3. Gotoh T,
    4. et al

    . In vivo single voxel proton MR spectroscopy in brain lesions with ring-like enhancement. NMR Biomed 2001; 14: 339– 49

    CrossRefPubMedWeb of Science
58. ↵
    1. Kimura T,
    2. Sako K,
    3. Tohyama Y,
    4. et al

    . Diagnosis and treatment of progressive space-occupying radiation necrosis following radiosurgery for brain metastasis: value of proton magnetic resonance spectroscopy. Acta Neurochir 2003; 145: 557– 64

    CrossRefPubMed
59. ↵
    1. Rutkowski T,
    2. Tarnawski R,
    3. Sokol M,
    4. et al

    . Proton-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys 2003; 56: 1381– 89

    CrossRefPubMedWeb of Science
60. ↵
    1. Weybright P,
    2. Maly P,
    3. Gomez Hassan D,
    4. et al

    . MR spectroscopy in the evaluation of recurrent contrast enhancing lesions in the posterior fossa after tumor treatment. Neuroradiology 2004; 46: 541– 59

    PubMed
61. ↵
    1. Bulakbasi N,
    2. Kocaoglu M,
    3. Ors F,
    4. et al

    . Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 2003; 24: 225– 33

    Abstract/FREE Full Text
62. ↵
    1. Lin A,
    2. Bluml S,
    3. Mamelak AN

    . Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors. J Neurooncol 1999; 45: 69– 81

    CrossRefPubMed
63. ↵
    1. Yang D,
    2. Korogi Y,
    3. Sugahara T,
    4. et al

    . Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002; 44: 656– 66

    CrossRefPubMed
64. ↵
    1. Wald LL,
    2. Nelson SJ,
    3. Day MR,
    4. et al

    . Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 1997; 87: 525– 34

    PubMedWeb of Science
65. ↵
    1. Kinoshita K,
    2. Tada E,
    3. Matsumoto K,
    4. et al

    . Proton MR spectroscopy of delayed cerebral radiation in monkeys and humans after brachytherapy. AJNR Am J Neuroradiol 1997; 18: 1753– 61

    Abstract
66. ↵
    1. Croteau D,
    2. Scarpace L,
    3. Hearshen D,
    4. et al

    . Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and quantitative histopathological analyses of patients with untreated glioma. Neurosurgery 2001; 49: 823– 29

    CrossRefPubMedWeb of Science
67. ↵
    1. Lazareff JA,
    2. Gupta RK,
    3. Alger J

    . Variation of post-treatment H-MRSI choline signal intensity in pediatric gliomas. J Neurooncol 1999; 41: 291– 98

    CrossRefPubMed
68. ↵
    1. McKnight TR,
    2. von dem Busche MH,
    3. Vigneron DB,
    4. et al

    . Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 2002; 97: 794– 802

    PubMedWeb of Science
69. ↵
    1. Elias A,
    2. Carlos RC,
    3. Smith E,
    4. et al

    . MR Spectroscopy Using Normalized and Non-Normalized Metabolite Ratios for Differentiating Recurrent Brain Tumor from Radiation Injury. Proceedings of the Radiological Society of North America, Chicago, Ill, November 30-December 5, 2008
70. ↵
    1. Lin A,
    2. Mamelak A,
    3. Ross BD

    . Effect of MRS on Clinical Decision Making in Brain Tumour Management. Proceedings of the International Society of Magnetic Resonance in Medicine, Denver, Colo, April 1–7, 2000
71. ↵
    1. Guyatt GH,
    2. Haynes RB,
    3. Jaeschke RZ,
    4. et al

    . Users’ Guides to Medical Literature XXV: evidence-based medicine—principles for applying the Users’ Guides to patient care. Evidence-Based Medicine Working Group. JAMA 2000; 284: 1290– 96

    CrossRefPubMedWeb of Science
72. ↵
    1. Smith EA,
    2. Carlos RC,
    3. Junck LR,
    4. et al

    . Developing a clinical decision model: use of MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast enhancing lesions. AJR Am J Roentgenol 2009; 192: W45– 52

    CrossRefPubMedWeb of Science